pharmacology principles Flashcards
(39 cards)
Pharmadynamics
The action of the drug on the body
Receptor interactions - agonist/antagonist -affinity or selectivity Dose response Curve effective dose in 50 nrats toxic dose in 50 rats MOA- Mechanism of Action Toxic action-adverse reaction/serious SE above toxic dose
Therapeutic Window
Between the effective dose and toxic dose
Therapeutic Index
Effective Dose
_________________ = Therapeutic Index
Toxic dose
TI score closer to 1 = more dangerous
Side effect
Unintended effects when dosage in therapeutic range
Potency
Amount of drug needed to produce a response
Effectiveness
Pharmacokinetics
Absorption Metabolism
Distribution Elimination
The body’s action on the drug
pharmacodynamic
drug profile remains unchanged throughout a persons lifetime ( what the drug does to the body
pharmacokinetics
changes with aging etc ( body response to drug)
Cipro vs Rocephin
Cipro given PO ( lipid soluble)
Rocephin given parenthaly (water soluble)
Absorption
Bioavailability- amount of drug reaching
circulation ( Crestor =lower dose for effectiveness)
Factors which affect
GI tract (lipid soluble-resists stomach acid)
Molecular weight
Absorption
CMAX
Maximum concentration per dose
Absorption
TMAX
Latency time required for effective dose
AUC
Area Under the Curve
Amount of drug in bloodstream
graph represents plasma blood concentration and time
Protein Binding
Coumadin interacts with highly bound medication
half life
no kidney excretion (secondary to protein)
> potential for drug to drug interaction
Applicable to long, intermediate and short acting insulin
Coumadin interaction with high protein binding medications
they compete for protein binding- coumadin has low affinity for protein–loss of competition with medication for protein binding–>increased amount of unbound coumadin (binding inactivates)–>coumadin in bloodstream=increased coumadin level
1st pass effect
Only affects PO medications
cannot be given po route if > 1st pass effect
Drug metabolized before reaching the bloodstream GI – Liver
Distribution
Volume of Distribution Vd
plasma concentration or amount of drug in body
Vd
Factors effecting
Blood flow Protein level Solubility Aging Hydration Organ size Special Tissues -Meds sequestered fat -estrogen, vitamin D bone- Boniva
Vd with aging
< amount of body weight as water < lean muscle mass (20%) >amount of body weight as fat < kidney weight <hepatic bloodflow
Distribution
Frick”s Law (Passive Dissusion)
Movement from > concentration to < concentration.
Types
Aqueous/ Lipid Diffusion
Carrier Transport
Endocytosis/pinocytosis -engulfing particles or H2O
Clearance
Rate that drug is completely removed by biotransformation/excretion.
renal -H2O soluble
hepatic-fat soluble
**Protein bound drugs cannot be excreted from kidneys.
Biotransformation
Imitrex
100mg po or 6mg SQ
Biotransformation of medication is changed by route of administration.
1st pass effect
Metabolism
Occurs in liver by Cytochrome P450 System.
47% CYP3A4
Metabolism
Phase I Reaction
Phase I- Oxidation, reduction,deamination, hydrolysis.
changed to water soluable
P450 enzymes